Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
F135L
can reduce steric hindrance at the end of the 5'-alkylthio binding subsite, so that longer 5'-substituents may be accommodated more easily in the MTAN2 active site
F148L
can reduce steric hindrance at the end of the 5'-alkylthio binding subsite
I132V
no significant structural change
I145V
no significant structural change
L168M
has a more extended side chain, may affect the binding of ligands at the 5'-alkylthio position
L181M
has a more extended side chain, may affect the binding of ligands at the 5'-alkylthio position
A15M
the mutant shows 14.5% catalytic efficiency compared to the wild type enzyme
D168A
the mutation completely abolishes activity
D168N
the mutation completely abolishes activity
E145A
the mutation completely abolishes activity
E145Q
the mutation completely abolishes activity
E18A
the mutation completely abolishes activity
E18Q
the mutation completely abolishes activity
M144A
the mutant shows 0.4% catalytic efficiency compared to the wild type enzyme
R164A
the mutant shows 15% catalytic efficiency compared to the wild type enzyme
R85A
the mutant shows 6.3% catalytic efficiency compared to the wild type enzyme
R85H
the mutant shows 7.1% catalytic efficiency compared to the wild type enzyme
S167A
the mutant shows 3.3% catalytic efficiency compared to the wild type enzyme
V34A
the mutant shows 12.5% catalytic efficiency compared to the wild type enzyme
V34I
the mutant shows 13.9% catalytic efficiency compared to the wild type enzyme
W179A
the mutant shows 3.3% catalytic efficiency compared to the wild type enzyme
W179F
the mutant shows 2.0% catalytic efficiency compared to the wild type enzyme
Y134A
the mutant shows 8.1% catalytic efficiency compared to the wild type enzyme
Y134F
the mutant shows 0.6% catalytic efficiency compared to the wild type enzyme
C136S
-
mutant is insensitive to oxidative inhibition
C223S
-
mutant is insensitive to oxidative inhibition
medicine
the enzyme is a therapeutic target for prostate cancer
V56I
-
natural polymorphism present in 7 of 9 melanoma cell lines, not in SK-Mel-28 and in HTZ19d
C136S
mutant is insensitive to oxidative inhibition
C223S
mutant is insensitive to oxidative inhibition
C259S/C261S/C262S
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 91°C. Specific activity is similar to the activity of the wild-type enzyme
C259S/C261S/C262S/C200S/C205S
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 73°C. Specific activity is similar to the activity of the wild-type enzyme
C259S/C261S/C262S/C200S/C205S/C138S
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 78°C. Specific activity is similar to the activity of the wild-type enzyme
C259S/C261S/C262S/C200S/C205S/C138S/C164S
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 73°C. Specific activity is similar to the activity of the wild-type enzyme
C259S/C261S
-
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 102°C. Specific activity is similar to the activity of the wild-type enzyme
-
C259S/C261S/C262S
-
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 91°C. Specific activity is similar to the activity of the wild-type enzyme
-
C259S/C261S/C262S/C200S/C205S
-
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 73°C. Specific activity is similar to the activity of the wild-type enzyme
-
C259S/C261S/C262S/C200S/C205S/C138S
-
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 78°C. Specific activity is similar to the activity of the wild-type enzyme
-
C262S
-
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 106°C. Specific activity is similar to the activity of the wild-type enzyme
-
N87T
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
Q289L
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
S12T
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
S12T/N87T
the mutant shows increased catalytic efficiencies with 5'-deoxy-5'-methylthioadenosine and 2'-deoxyadenosine and decreased catalytic efficiency with adenosine compared to the wild type enzyme
S12T/N87T/Q289L
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
C259S/C261S
-
mutant enzyme shows thermophilic and thermostable features significantly lower than those of the wild-type enzyme
C259S/C261S
-
in contrast wo wild-type C262S and C259S/C261S mutants show complete thermal denaturation curves with sigmoidal transitions centered at 102°C and 99°C respectively. Under reducing conditions these values decrease by 4°C and 8°C respectively, highlighting the important role exerted by the CXC disulfide on enzyme thermostability. The double mutant (the mutant lacking the structural CXC motif), has more impact on the thermostability of SsMTAPII than the single mutant
C259S/C261S
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 102°C. Specific activity is similar to the activity of the wild-type enzyme
C262S
-
mutant enzyme shows thermophilic and thermostable features significantly lower than those of the wild-type enzyme
C262S
-
in contrast wo wild-type C262S and C259S/C261S mutants show complete thermal denaturation curves with sigmoidal transitions centered at 102°C and 99°C respectively. Under reducing conditions these values decrease by 4°C and 8°C respectively, highlighting the important role exerted by the CXC disulfide on enzyme thermostability
C262S
mutation significantly reduces the optimal temperature for the catalytic activity. Strong destabilization for the folded structure of the enzyme, as inferred from the temperature for half inactivation, which decreases from 112°C (wild-type) to 106°C. Specific activity is similar to the activity of the wild-type enzyme
additional information
-
cell line DHL-9 contains a promotor sequence with a deletion of 14 bases, the deletion mutant allele is widespread throughout the japanese population and not responsible for the enzyme deficiency in this cell line
additional information
-
melanoma cell line HTZ19d is a deletion mutant without enzyme expression and activity
additional information
-
knockdown of Mtap protein by RNA interference in L-alanosine-resistant HuCCT1 cells conferred sensitivity to this agent, L-alanosine shows robust growth inhibition in MTAP-negative biliary cancer cell lines CAK-1 and GBD-1 accompanied by striking depletion of intracellular ATP and failure to rescue this depletion via addition of exogenous methylthioadenosine, overview